The Online Books Page

Drug Evaluation

See also what's at your library, or elsewhere.

• Drug Evaluation -- Congresses
• Drug Evaluation -- United States
• Drug Evaluation, Preclinical

• Guidelines for the clinical evaluation of hypnotic drugs. (Dept. of Health, Education, and Welfare, Public Health Service, Food and Drug Administration ;, 1977), by United States Food and Drug Administration (page images at HathiTrust)
• Guidelines for the clinical evaluation of antidiarrheal drugs. (Dept. of Health, Education, and Welfare, Public Health Service, Food and Drug Administration ;, 1977), by United States Food and Drug Administration (page images at HathiTrust)
• Guidelines for the clinical evaluation of anti-arrhythmic drugs. (Dept. of Health, Education, and Welfare, Public Health Service, Food and Drug Administration ;, 1977), by United States Food and Drug Administration (page images at HathiTrust)
• Guidelines for the clinical evaluation of gastric secretory depressant (GSD) drugs. (Dept. of Health, Education, and Welfare, Public Health Service, Food and Drug Administration, 1977), by United States Food and Drug Administration (page images at HathiTrust)
• General considerations for the clinical evaluation of drugs in infants and children. (Dept. of Health, Education, and Welfare, Public Health Service, Food and Drug Administration ;, 1977), by United States. Food and Drug Administration. Bureau of Drugs (page images at HathiTrust)
• Guidelines for the clinical evaluation of antidepressant drugs. (U.S. Dept. of Health, Education, and Welfare, Public Health Service, Food and Drug Administration ;, 1977), by United States. Food and Drug Administration. Bureau of Drugs (page images at HathiTrust)
• Guidelines for the clinical evaluation of anticonvulsant drugs (adults and children). (U.S. Dept. of Health, Education, and Welfare, Public Health Service, Food and Drug Administration ;, 1977), by United States. Food and Drug Administration. Bureau of Drugs (page images at HathiTrust)
• Guidelines for the clinical evaluation of general anesthetics. (U.S. Dept. of Health, Education, and Welfare, Public Health Service, Food and Drug Administration, 1977), by United States. Food and Drug Administration. Bureau of Drugs (page images at HathiTrust)
• Guidelines for the clinical evaluation of anti-anginal drugs. (U.S. Dept. of Health, Education, and Welfare, Public Health Service, Food and Drug Administration ;, 1977), by United States. Food and Drug Aministration. Bureau of Drugs (page images at HathiTrust)
• Guidelines for the clinical evaluation of anti-inflammatory drugs (adults and children). (U.S. Dept. of Health, Education, and Welfare, Public Health Service, Food and Drug Administration, 1978), by United States. Food and Drug Administration. Bureau of Drugs (page images at HathiTrust)
• Guidelines for the clinical evaluation of antianxiety drugs. (U.S. Dept. of Health, Education, and Welfare, Public Health Service, Food and Drug Administration ;, 1977), by United States. Food and Drug Administration. Bureau of Drugs (page images at HathiTrust)
• Guidelines for the clinical evaluation of anti-infective drugs (systemic) (adults and children). (U.S. Dept. of Health, Education, and Welfare, Public Health Service, Food and Drug Administration ;, 1977), by United States. Food and Drug Administration. Bureau of Drugs (page images at HathiTrust)
• Guidelines for the clinical evaluation of local anesthetics. (U.S. Dept. of Health, Education, and Welfare, Public Health Service, Food and Drug Administration ;, 1977), by United States. Food and Drug Administration. Bureau of Drugs (page images at HathiTrust)
• General considerations for the clinical evaluation of drugs. (U.S. Dept. of Health, Education, and Welfare, Public Health Service, Food and Drug Administration ;, 1977), by United States. Food and Drug Administration. Bureau of Drugs (page images at HathiTrust)
• Guidelines for the clinical evaluation of radiopharmaceutical drugs. (Dept. of Health, Education, and Welfare, Public Health Service, Food and Drug Administration ;, 1977), by United States. Food and Drug Administration. Bureau of Drugs (page images at HathiTrust)
• Preclinical and clinical testing by the pharmaceutical industry, 1980--DMSO : hearing before the Subcommittee on Health and Scientific Research of the Committee on Labor and Human Resources, United States Senate, Ninety-sixth Congress, second session, on examination of the testing of DMSO and FDA's role in the process, July 31, 1980. (U.S. G.P.O. :, 1980), by United States. Congress. Senate. Committee on Labor and Human Resources. Subcommittee on Health and Scientific Research (page images at HathiTrust)
• The Food and Drug Administration's process for approving new drugs : report (U.S. G.P.O. :, 1980), by Research United States. Congress. House. Committee on Science and Technology. Subcommittee on Science (page images at HathiTrust)
• New drug development in the United States (Dept. of Health & Human Services, Public Health Service, Food and Drug Administration, 1995), by United States Food and Drug Administration (page images at HathiTrust)
• FDA's drug and device review process : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, second session, February 6, 1992. (U.S. G.P.O. :, 1992), by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations (page images at HathiTrust)
• FDA needs stronger controls over the approval process for new animal drugs (The Office ;, 1992), by United States General Accounting Office and United States. Congress. House of Representatives. Committee on Government Operations. Human Resources and Intergovernmental Relaltions Subcommittee (page images at HathiTrust)
• FDA review times : statement of Mary R. Hamilton, Director of Program Evaluation in Human Services Areas, Program Evaluation and Methodology Division, before the Subcommittee on Health and Environment, Committee on Commerce, House of Representatives (The Office ;, 1996), by Mary R. Hamilton, United States. Congress. House. Committee on Commerce. Subcommittee on Health and the Environment, and United States General Accounting Office (page images at HathiTrust)
• ADP planning : FDA's plans to improve processing of medical device and drug applications : report to congressional requesters (The Office, 1989), by United States General Accounting Office (page images at HathiTrust)
• The microscopical examination of foods and drugs; a practical introduction to the methods adopted in the microscopical examination of foods and drugs, in the entire, crushed and powdered states. (Blakiston, 1910), by Henry George Greenish (page images at HathiTrust)
• Guidelines for the clinical evaluation of local anesthetics. (Rockville, Maryland : U.S. Dept. of Health and Human Services, Public Health Service, Food and Drug Administration, [1982], 1982), by United States. Food and Drug Administration. Division of Surgical Dental Drug Products (page images at HathiTrust)
• Preclinical and clinical testing by the pharmaceutical industry, 1975- : joint hearings before the Subcommittee on Health of the Committee on Labor and Public Welfare and the Subcommittee on Administrative Practice and Procedure of the Committee on the Judiciary, United States Senate, Ninety-fourth Congress, first session- on examination of the process of drug testing and FDA's role in the regulation and conditions under which such testing is carried out. (U. S. Govt. Print. Off., 1976), by United States Senate Committee on Labor and Public Welfare and United States Senate Committee on the Judiciary (page images at HathiTrust)
• New drug evaluation statistical report. (U.S. Dept. of Health and Human Services, Public Health Service, Food and Drug Administration, Center for Drugs and Biologics, Office of Management ;, 1987), by Center for Drugs and Biologics (U.S.). Office of Management (page images at HathiTrust)
• Human drug testing by the CIA, 1977 : hearings before the Subcommittee on Health and Scientific Research of the Committee on Human Resources, United States Senate, Ninety-fifth Congress, first session, on S. 1893 ... September 20 and 21, 1977. (U.S. Govt. Print. Off. :, 1977), by United State Senate Subcommittee on Health and Scientific Research (page images at HathiTrust)
• The documentation of clinical psychotropic drug trials : [a workbook and user's guide to understanding and interpreting the data processing and output of the Biometric Laboratory Information Processing System (BLIPS), George Washington University, and the Early Clinical Drug Evaluation Unit (ECDEU), NIMH] (The Institute, 1973), by National Institute of Mental Health (U.S.). Psychopharmacology Research Branch (page images at HathiTrust; US access only)

• Medications development for the treatment of pregnant addicts and their infants (U.S. Dept. of Health and Human Services, Public Health Service, National Institute of Health, National Institute on Drug Abuse, 1995), by Loretta P. Finnegan, C. Nora Chiang, and National Institute on Drug Abuse (page images at HathiTrust)

• The need for FDA regulatory reform to protect the health and safety of Americans : hearing before the Subcommittee on National Economic Growth, Natural Resources, and Regulatory Affairs of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fourth Congress, first session, June 9, 1995. (U.S. G.P.O. :, 1996), by Natural Resources United States. Congress. House. Committee on Government Reform and Oversight. Subcommittee on National Economic Growth (page images at HathiTrust)
• From test tube to patient : new drug development in the United States. (Dept. of Health & Human Services, Public Health Service, Food and Drug Administration, 1988), by United States Food and Drug Administration (page images at HathiTrust)
• Investigator's handbook : a manual for participants in clinical trials of investigational agents sponsored by the Division of Cancer Treatment, National Cancer Institute. (Cancer Therapy Evaluation Program, Division of Cancer Treatment, National Cancer Institute, 1987), by National Cancer Institute (U.S.). Cancer Therapy Evaluation Program (page images at HathiTrust)
• Competitive problems in the drug industry : drug testing : summary and analysis, Select Committee on Small Business, United States Senate (U.S. Govt. Print. Off. :, 1979), by Library of Congress. Congressional Research Service and United States. Congress. Senate. Select Committee on Small Business (page images at HathiTrust)
• FDA introduction to total drug quality. ([Rockville, Md.] : [U.S. Dept. of Health, Education, and Welfare, Public Health Service, Food and Drug Administration]] ; [[Washington] : [For sale by the Supt. of Docs., U.S. Govt. Print.], [1973], 1973), by United States Food and Drug Administration (page images at HathiTrust)

• The regulation of new drugs by the Food and Drug Administration : the new drug review process : hearings before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-seventh Congress, second session, August 3 and 4, 1982. (U.S. G.P.O. :, 1982), by United States. Congress. House. Committee on Government Operations. Intergovernmental Relations and Human Resources Subcommittee (page images at HathiTrust)

• The regulation of new drugs by the Food and Drug Administration : the new drug review process : hearings before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-seventh Congress, second session, August 3 and 4, 1982. (U.S. G.P.O. :, 1982), by United States. Congress. House. Committee on Government Operations. Intergovernmental Relations and Human Resources Subcommittee (page images at HathiTrust)

• From test tube to patient : new drug development in the United States. (Dept. of Health & Human Services, Public Health Service, Food and Drug Administration, 1988), by United States Food and Drug Administration (page images at HathiTrust)
• Competitive problems in the drug industry : drug testing : summary and analysis, Select Committee on Small Business, United States Senate (U.S. Govt. Print. Off. :, 1979), by Library of Congress. Congressional Research Service and United States. Congress. Senate. Select Committee on Small Business (page images at HathiTrust)

• Guideline for the format and content of the nonclinical pharmacology/toxicology section of an application. (Center for Drugs and Biologics, Food and Drug Administration, Dept. of Health and Human Services, 1987), by Center for Drugs and Biologics (U.S.) (page images at HathiTrust)
• Preclinical and clinical testing by the pharmaceutical industry, 1980--DMSO : hearing before the Subcommittee on Health and Scientific Research of the Committee on Labor and Human Resources, United States Senate, Ninety-sixth Congress, second session, on examination of the testing of DMSO and FDA's role in the process, July 31, 1980. (U.S. G.P.O. :, 1980), by United States. Congress. Senate. Committee on Labor and Human Resources. Subcommittee on Health and Scientific Research (page images at HathiTrust)
• The Food and Drug Administration's process for approving new drugs : report (U.S. G.P.O. :, 1980), by Research United States. Congress. House. Committee on Science and Technology. Subcommittee on Science (page images at HathiTrust)
• New drug development in the United States (Dept. of Health & Human Services, Public Health Service, Food and Drug Administration, 1995), by United States Food and Drug Administration (page images at HathiTrust)
• FDA premarket approval : process of approving olestra as a food additive : report to congressional requesters. (U.S. General Accounting Office, 1992), by United States General Accounting Office (page images at HathiTrust)
• Preclinical and clinical testing by the pharmaceutical industry, 1975- : joint hearings before the Subcommittee on Health of the Committee on Labor and Public Welfare and the Subcommittee on Administrative Practice and Procedure of the Committee on the Judiciary, United States Senate, Ninety-fourth Congress, first session- on examination of the process of drug testing and FDA's role in the regulation and conditions under which such testing is carried out. (U. S. Govt. Print. Off., 1976), by United States Senate Committee on Labor and Public Welfare and United States Senate Committee on the Judiciary (page images at HathiTrust)
• Anticonvulsant Screening Project : Antiepileptic Drug Development Program (U. S. Dept. of Health, Education, and Welfare, Public Health Service, National Institutes of Health, 1978), by National Institute of Neurological and Communicative Disorders and Stroke. Epilepsy Branch (page images at HathiTrust)

Items below (if any) are from related and broader terms.